Download
1 / 18

Objectives - PowerPoint PPT Presentation


  • 96 Views
  • Uploaded on

Objectives. Efficacy Safety Adverse effects Copper intrauterine device(IUD) LNG-releasing intrauterine devices(LONG-IUS). Methods. Retrospective manner of 8410 women who had received a IUD in FPC from January 1983 to December 2005.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Objectives' - vonda


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Objectives
Objectives

  • Efficacy

  • Safety

  • Adverse effects

    Copper intrauterine device(IUD)

    LNG-releasing intrauterine devices(LONG-IUS)


Methods
Methods

  • Retrospective manner of 8410 women who had received a IUD in FPC from January 1983 to December 2005.

  • 410 women were excluded: 2.02% (emergency contraception method) and 2.9% (were lost). Therefore, total study population is 8.000 patients.

  • Patients was selected according to World Health Organization elegibility criteria.

  • Different types of copper IUD were prescribed according to the length of uterine cavity (measured by transabdominal ultrasound); one type of LNG-IUD was prescribed.

34 years: 2 chilbirth, 16º cicle day

Longitudinal diameter

Transverse diameter


Model and number of IUDs Insert/ women

First IUD 2th IUD 3th IUD

Model N % N % N %

Copper IUD

MLcu250 st. 72 1.5 28 1.2 5 0.8

MLcu250sho 55 1.1 21 0.9 4 0.6

MLcu250min 34 0.7 13 0.5 3 0.4

MLcu373st 93 1.9 36 1.5 7 1.1

MLcu373sho 58 1.2 22 0.9 5 0.8

MLcu373min 17 0.3 7 0.3 2 0.3

Tplata200st 152 3.1 71 2.9 27 4.1

Tplata200min 68 1.4 26 1.0 6 0.9

Tplata373st 353 7.2 182 7.5 45 6.8

Tplata373min 125 2.5 56 2.3 2 0.3

NovaT 558 11.3 274 11.3 48 7.3

Tcu340st 929 18.9 444 18.3 127 19.3

Tcu340min 440 8.9 221 9.1 44 6.7

GyneT380 360 7.3 183 7.6 57 8.7

FlexiT300st 370 7.5 185 7.6 75 11.4

FlexiT300+ 127 2.6 74 3.1 19 2.9

EffiT380st 397 8.1 209 8.6 74 11.2

EffiT380cor 79 1.6 34 1.4 17 2.6

Gynefix 375 7.6 194 8.0 91 13.8

Mirena 260 5.3 140 5.8 0 0

Total 4922 100 2420 100 658 100

61.5% 30.3% 8.2%


  • All IUDs were inserted during menstruation, prophylactic antibiotics were not used and, innulliparous women vaginal prostaglandins (misoprostol 100 mg) were administered 6- 8 hours before the insertion.

  • Monitoring visits before 1, 6 and 12 months during the first year, and then annually until the removal of the IUD.

  • IUDs contraception was mantained up to five years. In women older than 45 years was removed at menopause (at least one year of amenorrhea).


  • Studied variables: antibiotics were not used and, in

    - age

    - parity

    - previous contraception method

    - type of IUD

    - number of IUD inserted per patient

    - complications during the insertion

    - duration of use

    - causes of removal

    - adverse effects (dysmenorrhea, bleeding disorders, expulsion, pelvic inflamatory disease, uterine perforation) and efficacy.


Results
Results antibiotics were not used and, in

  • Mean age: 30.5 years (18-44)

  • Parity:

    Nulliparous 1404 17,6%

    At least one vaginal delivery 6040 75,5%

    Caesarean 556 6,9%

    Total 8000 100%


Number of iud for women
Number of IUD for women antibiotics were not used and, in

  • 1 IUD 4920 61.5%

  • 2 IUD 2416 30.3%

  • 3 IUD 664 8.2%

    Total 8000 100%


Mean duration of use of the iud
Mean Duration of Use of the IUD antibiotics were not used and, in

  • First IUD 52 months

  • Second IUD 36 months

  • Third IUD 23 months


Previous Contraception Method antibiotics were not used and, in

Method Number %

OC 3200 40.0

IUD 1600 20.0

Barrier method 1352 16.9

Natural 952 11.9

None 544 6.8

Others 352 4.4

Total 8000 100


Insertion Complications antibiotics were not used and, in

Number %

Without difficulty 7498 93.8

Difficult Insertion 70 0.9

Cervical dilatation 496 6.2

Light to moderate pain 392 4.9

Severe pain 30 0.4

Uterine perforation 0 0.0

Total 8000 100


Complications of IUD use in the first year of follow-up antibiotics were not used and, in

Expulsion 74 (1.04%)

P.I.D. 93 (1.3%)

Bleeding disorders 357 (5%)

Severe dysmenorrhea 35 (0.5%)

Good tolerance 6598 (91.9%)

Total 7157 (100%)

559 (7.8%)


Complications that forced IUD removal. First and fifth years of follow-up data

First year Fifth year

(N= 7157) (N = 4225)

P.I.D. 78 (1.1%) 63 (1.5%)

Severe dysmenorrhea 32 (0.45%) 21 (0.5%)

Bleeding disorders 178 (2.5%) 211 (5%)

Migrations 0 (0.0%) 3 (0.01%)

Total 288 (4%) 298 (7.1%)


Return to fertility after iud removal in the first year
Return to fertility after of follow-up data IUD removal in the first year

Pregnancy 5353 (74.9%)

No Pregnancy 1769 (24.1%)

Total 7122 (100%)


Method Efficacy of follow-up data

  • Five pregnancies accumulated in 5 years:

    Pearl index/5 years =0.26

  • 24 pregnancies accumulated in 22

    years:

    Pearl index/22 years = 0.3


LNG-Releasing IUD, 400 women of follow-up data

  • Most common adverse effects, were mastodynia

  • and weight gain both with a rate lower than 1.5%.

  • - No cases of uterine perforation or pregnancy

  • occurred.

  • - Pearl index at five years of follow up was zero.


  • Changes of menses
    - Changes of menses. of follow-up data

    LNG-Releasing IUD, 400 women


    Conclusions: of follow-up data

    * IUD is a safe and effective contraception method

    in appropriately selected patients.

    * The rate of return to fertility is high, as is its efficacy (Pearl index

    equal to 0.3 during the 22 years period of the study).

    * Adverse effects are rare. Globally, main complications are PID

    and abnormal bleeding. In contrast, use of LNG-IUD is

    associated with oligomenorrhea in a percentage of patients,

    which it could be considerated a favourable effect for women

    with hypermenorrhea, either secondary to copper intrauterine

    device use or spontaneous


    ad